Registro:

Referencias:

• Mason, H.S., Lam, D.M., Arntzen, C.J., Expression of hepatitis B surface antigen in transgenic plants (1992) Proc. Natl. Acad. Sci. USA, 89, pp. 11745-11749
• Giddings, G., Allison, G., Brooks, D., Carter, A., Transgenic plants as factories for biopharmaceuticals (2000) Nat. Biotechnol., 18, pp. 1151-1155
• Daniell, H., Streatfield, S.J., Wycoff, K., Medical molecular farming: Production of antibodies, biopharmaceutical and edible vaccines in plants (2001) Trends Plant Sci., 6, pp. 219-226
• Streatfield, S.J., Howard, J.A., Plant-based vaccines (2003) Int. J. Parasitol., 33, pp. 479-493
• Arakawa, T., Yu, J., Chong, D.K., Hough, J., Engel, P.C., Langridge, W.H., A plant-based cholera toxin B subunnit-insulin fusion protein protects against the development of autoimmune diabetes (1998) Nat. Biothechnol., 16, pp. 934-938
• Mason, H.S., Haq, T.A., Clements, J.D., Arntzen, C.J., Edible vaccine protects mice against Escherichia coli heat-labile enterotoxin (LT): Potatoes expressing a systhetic LT-B gene (1998) Vaccine, 16, pp. 1336-1343
• Richter, L.J., Thanavala, Y., Arntzen, C.J., Mason, H.S., Production of hepatitis B surface antigen in transgenic plants for oral immunization (2000) Nat. Biotechnol., 18, pp. 1167-1171
• Lauterslager, T.G.M., Florack, D.E.A., Van Der Wal, T.J., Molthoff, J.W., Langeveld, J.P.M., Bosch, D., Oral immunization of naive and primed animals with transgenic potato tubers expressing LT-B (2001) Vaccine, 19, pp. 2749-2755
• Huang, Y., Liang, W., Pan, A., Zhou, Z., Huang, C., Chen, J., Production of FaeG, the mejor subunit of K88 fimbriae, in transgenic tobacco plants and its immunogenicity in mice (2003) Infect. Immun., 71, pp. 5436-5439
• Peréz-Filgueira, D.M., Zamorano, P.I., Domínguez, M.G., Taboga, O., Del Mdico Zajac, M.P., Puntel, M., Bovine herpes virus gD protein produced in plants using a recombinnant tobacco mosaic virus (TMV) vector possesses authentic antigenicity (2003) Vaccine, 21, pp. 4201-4209
• Fischer, R., Vaquero-Martin, C., Sack, M., Drossard, J., Emans, N., Commandeur, U., Towards molecular farming in the future: Transient protein expression in plants (1999) Biotechnol. Appl. Biochem., 30, pp. 113-116
• Sala, F., Rigano, M.M., Barbante, A., Basso, B., Walmsley, A.M., Castiglione, S., Vaccine antigen production in transgenic plants: Strategies, gene constructs and perspective (2003) Vaccine, 21, pp. 803-808
• Kapila, J., De Rycke, R., Van Montagu, M., Angenon, G., An Agrobacterium-mediated transient gene expression system in intact leaves (1997) Plant Sci., 122, pp. 101-108
• Tenter, A.M., Heckeroth, A.R., Weiss, L.M., Toxoplasma gondii: From animals to humans (2000) Int. J. Parasitol., 30, pp. 1217-1258
• Dubey, J.P., Status of toxoplasmosis in sheep and goats in the United States (1990) J. Am. Vet. Med. Assoc., 196, pp. 259-262
• Duncanson, P., Terry, R.S., Smith, J.E., Hide, G., High levels of congenital transmission of Toxoplasma gondii in a commercial sheep flock (2001) Int. J. Parasitol., 31, pp. 1699-1703
• Frenkel, J.K., Escajadillo, A., Cyst rupture as a pathogenic mechanism of toxoplasmic encephalitis (1987) Am. J. Trop. Med. Hyg., 36, pp. 517-522
• Bout, D.T., Mévélec, M.N., Velge-Roussel, F., Dimier-Poisson, I., Lebrun, M., Prospects for a human Toxoplasma vaccine (2002) Curr. Drug. Targets Immune Endocr. Metabol. Disord., 2, pp. 227-234
• Bhopale, G.M., Development of a vaccine for toxoplasmosis: Current status (2003) Microb. Infect., 5, pp. 457-462
• Nagel, S.D., Boothroyd, J.C., The mayor surface antigen, P30, of Toxoplasma gondii anchored by a glycolipid (1989) J. Biol. Chem., 264, pp. 5569-5574
• Skryabin, K.G., Kraev, A.S., Morosov, S.Y., Rosanov, M.N., Chernov, B.K., Lukasheva, L.I., The nucleotide sequence of potato virus X RNA (1988) Nucleic Acids Res., 16, pp. 10929-10930
• Chapman, S., Hills, G., Watts, J., Baulcombe, D., Virus X as a vector for gene expression in plants (1992) Plant J., 2, pp. 549-557
• Santa Cruz, S., Chapman, S., Roberts, A.G., Roberts, I.R., Prior, D.A.M., Oparka, K.J., Assembly and movement of a plant virus carrying a green fluorescent protein overcoat (1996) Proc. Natl. Acad. Sci. USA, 93, pp. 6286-6290
• Franconi, R., Di Bonito, P., Dibello, F., Accardi, L., Muller, A., Cirilli, A., Plant-derived human papillomavirus 16 E7 oncoprotein induces immune response and specific tumor protection (2002) Cancer Res., 62, pp. 3654-3658
• Orman, B.E., Celnik, R.M., Mandel, M.A., Torres, T.N., Mentaberry, A.N., Complete nucleotide sequence of a South American isolate of potato virus X (1991) Virus Res., 16, pp. 293-305
• Nigro, M., Gutierrez, A., Hoffer, A.M., Clemente, M., Kanfer, F., Carral, L., Evaluation of Toxoplasma gondii recombinant proteins for the diagnosis of recently acquired toxoplasmosis by an immunoglobulin G analysis (2003) Diagn. Microbiol. Infect. Dis., 47, pp. 609-613
• Mallory, A.C., Parks, G., Endres, M.W., Baulcombe, D., Bowman, L.H., Pruss, G.J., Vance, V.B., The amplicon-plus system for high-level expression of transgenes in plants (2002) Nat. Biothecnol., 20, pp. 622-625
• Brigneti, G., Voinnet, O., Li, W.X., Ji, L., Ding, S.W., Baulcombe, D., Viral pathogenicity determinant are suppressors of transgene silencing in Nicotiana benthamiana (1998) EMBO J., 17, pp. 6739-6746
• Harning, D., Spenter, J., Metsis, A., Vuust, J., Petersen, E., Recombinant Toxoplasma gondii surface Antigen 1 (P30) expressed in Escherichia coli is recognized by human Toxoplasma-specific immunoglobulin M (IgM) and IgG antibodies (1996) Clin. Diagn. Lab. Immunol., 3, pp. 355-357
• Chen, X.G., Gong, Y.H.U., Lun, Z.R., Fung, M.C., High- level expression and purification of immunogenic recombinant SAG1 (p30) of Toxoplasma gondii in Escherichia coli (2001) Protein Expr. Purif., 23, pp. 33-37
• Letourner, O., Gervasi, G., Gaia, S., Pages, J., Watelet, B., Jolivet, M., Characterization of Toxoplasma gondii surface, antigen 1 (SAG1) secreted from Pichia pastoris: Evidence of hyper O-glycosylation (2001) Biotechnol. Appl. Biochem., 33, pp. 35-45
• Marti, M., Li, Y., Kohler, P., Hehl, A.B., Conformationally correct expression of membrane-anchored Toxoplasma gondii SAG1 in the primitive protozoan Giardia duodenalis (2002) Infect. Immunol., 70, pp. 1014-1016
• Kim, K., Bulow, R., Kampmeier, J., Boothroyd, J.C., Conformationally appropriate expression of the Toxoplasma antigen SAG1 (p30) in CHO cells (1994) Infect. Immunol., 62, pp. 203-209
• Meek, B., Diepersloot, R.J., Van Gool, T., Speijer, D., Peek, R., IgM recognition of recombinant Toxoplasma gondii antigens by sera of acutely or latently infected humans (2003) Diagn. Microbiol. Infect. Dis., 45, pp. 45-52
• Biemans, R., Gregoire, D., Haumont, M., Bosseloir, A., Garcia, L., Jacquet, L., The conformation of purified Toxoplasma gondii SAG1 antigen, secreted from engineered Pichia pastoris, is adequate for serorecognition and cell proliferation (1998) J. Biotechnol., 66, pp. 137-146
• Vaquero, C., Sack, M., Chandler, J., Drossard, J., Schuster, F., Moneck, M., A carcinoembryonic antigen-specific antibody produced in tobacco (1999) Proc. Natl. Acad. Sci. USA, 96, pp. 11128-11133
• Desolme, B., Mévélec, M.N., Buzoni-Gatel, D., Bout, D., Induction of protective immunity against toxoplasmosis in mice by DNA immunization with a plasmid encoding Toxoplasma gondii Gra4 gene (2000) Vaccine, 18, pp. 2512-2521
• Vercammen, M., Scorza, T., Huygen, K., De Braekeleer, J., Diet, R., Jacobs, D., DNA vaccination with genes encoding Toxoplasma gondii antigens GRA1, GRA7, and ROP2 induces partially protective immunity against lethal challenge in mice (2000) Infect. Immunol., 68, pp. 38-45
• Martin, V., Supanitsky, A., Echeverria, P.C., Litwin, S., Tanos, T., De Roodt, A.R., Recombinant Gra4 or Rop2 combined with alum or gra4 DNAa provides partial protection in chronic murine models of toxoplamosis (2004) Clin. Diagn. Lab. Immunol., 11, pp. 704-710

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------